【義大利】Italy Starts to Look Ahead to 'Phase Two' as COVID-19 Death Toll Slows


A woman wearing a protective mask walks on the Rialto Bridge on Palm Sunday, following the coronavirus disease (COVID-19) outbreak in Venice, Italy, April 5, 2020.

(REUTERS/Manuel Silvestri)


MILAN (Reuters) - Italy reported its lowest daily COVID-19 death toll for more than two weeks on Sunday as authorities began to look ahead to a second phase of the battle against the new coronavirus once the lockdown imposed almost a month ago is eventually eased.


The toll from the world's deadliest outbreak reached 15,887, almost a quarter of the global death total, but the rise of 525 from a day earlier was the smallest daily increase since March 19, while the number of patients in badly stretched intensive care units fell for a second day running. "The curve has reached a plateau and begun to descend," said Silvio Brusaferro, head of the Istituto Superiore di Sanità, Italy's top health institute. "It is a result that we have to achieve day after day." "If this is confirmed, we need to start thinking about the second phase and keep down the spread of this disease." The total number of confirmed cases of the novel coronavirus rose by 4,316 to 128,948, the lowest increase in five days, which added to signs the epidemic has reached a plateau, about six weeks after it broke out in northern Italy on Feb. 21. Sunday's figures added to growing signs the tough restrictions on movement and public gatherings imposed across the country on March 9 were having an effect in containing the epidemic, but officials have been desperate to avoid a letup. "Don't lower our guard, stay at home," Angelo Borelli, head of the Civil Protection department, told a daily briefing. But alongside the public health crisis, the government is also grappling with the economic devastation caused by the sudden halt to business across the country. Following several days of encouraging data, Health Minister Roberto Speranza outlined a series of measures, including more testing and a beefed up local health system, intended to allow a gradual easing until a vaccine might be developed. "There are difficult months ahead. Our task is to create the conditions to live with the virus," at least until a vaccine is developed, he told the daily La Repubblica newspaper. The national lockdown, strictly limiting people's movements and freezing all non-essential economic activity, will officially last until at least April 13 but it is widely expected to be extended. Speranza said it was too early to say when it could be lifted. The minister said he had issued a note outlining five principles around which the government planned to manage the so-called "phase two" of the emergency, when lockdown restrictions began to be eased but before a full return to normal conditions. He said social distancing would have to remain, with wider use of individual protection devices such as face masks, while local health systems would be strengthened, to allow a faster and more efficient treatment of suspected COVID-19 cases. Testing and "contact tracing" would be extended, including with the use of smartphone apps and other forms of digital technology while a network of hospitals dedicated solely to treating COVID-19 patients would be set up. (Reporting by Giulio Piovaccari; Editing by Frances Kerry and Pravin Char)


資料來源:US News https://www.usnews.com/news/world/articles/2020-04-05/as-covid-19-deaths-steady-italys-health-minister-eyes-next-phase

最新文章

查看全部

【台灣】國內累計443人確診,427人解除隔離

中央流行疫情指揮中心今(1)日表示,國內昨(31)日新增237例新型冠狀病毒肺炎相關通報,截至目前累計通報72,319例(含71,287例排除),其中443例確診(今日新增案443),分別為352例境外移入,55例本土病例及36例敦睦艦隊。確診個案中7人死亡,427人解除隔離,其餘持續住院隔離中。 指揮中心指出,全球累計6,195,424例確診,分布於187個國家/地區;病例數以美國1,817,7

【台灣】建立健康安全防護網,持續優化科技智慧防疫

中央流行疫情指揮中心今(1)日表示,科技防疫在本次國內COVID-19(武漢肺炎)疫情防治扮演極為重要的角色,我國在疫情初期,即以超前部署的概念,規劃可能需要的防疫作為,從邊境管制到社區管理,建置多項智慧防疫系統及訂定「實聯制措施指引」,多方面保護民眾的健康及隱私。 指揮中心指出,我國智慧防疫系統包括「入境檢疫系統」,從旅客入境健康聲明即開始彙整相關資料,並拋轉至「防疫追蹤系統」,提供第一線民、警

【台灣】國衛院新冠病毒快篩試劑 非專屬授權技轉成果說明

國家衛生研究院(國衛院)與國防醫學院預防醫學研究所(國防醫學院預醫所)共同合作之「新型冠狀病毒快篩試劑」已於4月8日舉辦非專屬授權技術說明會,逾20家國內快篩試劑相關廠商共同與會,並陸續收到十多家具相關生產製造經驗之廠商投件申請。其中,有多家廠商採取策略聯盟的方式遞件申請,透過結合上、中、下游的力量,包含抗體生產、試劑製造到臨床試驗等重要環節,期盼藉由運用所屬技術優勢發揮加乘效果,以利快速完成快篩

版權所有 教育商城 |  TaiDa International Education Services

Copyright© 2020 All Rights Reserved.

本網頁各連結標題及連結內容歸原權利人所有 /  未經書面允許 不得轉載或節錄引用